Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
DiaMedica Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price (2)(3) | Fee Rate | Amount of Registration Fee |
Newly Registered Securities |
Fees to Be Paid | Equity | Common Shares, no par value per share | Rule 457(c) | 4,720,000 common shares | $2.89 | $13,617,908.00 | $147.60 per $1,000,000 | $2,010.00 |
Fees Previously Paid | - | - | - | - | - | - | - | - |
| Total Offering Amounts | | $13,617,908.00 | | $2,010.00 |
| Total Fees Previously Paid | | | | - |
| Total Fee Offsets | | | | - |
| Net Fee Due | | | | $2,010.00 |
(1) | Pursuant to Rule 416, there are also being registered such indeterminable additional securities as may be issued to prevent dilution as a result of stock splits, stock dividends, or similar transactions. |
(2) | Estimated solely for the purpose of calculating the registration fee. The estimate is made pursuant to Rule 457(c) of the Securities Act of 1933 based on $2.89 per share, which represents the average of the high and low sales prices of the registrant’s common shares on July 5, 2024 as reported on The Nasdaq Capital Market. |
(3) | The registrant will not receive any proceeds from the sale of its common shares by the selling shareholders. |